Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies
Abstract Background Analytical treatment interruptions (ATI) are commonly used clinical endpoints to assess interventions aimed at curing HIV or achieving antiretroviral therapy (ART)-free HIV remission. Understanding the acceptability of ATI amongst people living with HIV (PLHIV) and their HIV heal...
Main Authors: | Jillian S. Y. Lau, Miranda Z. Smith, Brent Allan, Cipriano Martinez, Jennifer Power, Sharon R. Lewin, James H. McMahon |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | AIDS Research and Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12981-020-00321-z |
Similar Items
-
Recruitment and ethical considerations in HIV cure trials requiring treatment interruption
by: Michael P. Arnold, et al.
Published: (2015-01-01) -
HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper
by: S. Fidler, et al.
Published: (2021-03-01) -
Characterization of Physicians That Might Be Reluctant to Propose HIV Cure-Related Clinical Trials with Treatment Interruption to Their Patients? The ANRS-APSEC Study
by: Christel Protiere, et al.
Published: (2020-06-01) -
Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
by: Evelyn Y. Bonney, et al.
Published: (2021-03-01) -
A landscape analysis of HIV cure-related clinical research in 2019
by: Liz Barr, et al.
Published: (2020-11-01)